To embed, copy and paste the code into your website or blog: "The gathering and transmitting of personal data represents a major cyber threat to medical devices and must be extremely carefully thought through." Q: The FDA’s stance on a regulatory framework for artificial intelligence and machine learning (AI/ML) software as a medical device is continuously evolving. Could you explain the history? A: Artificial intelligence (AI) is “adaptive,” meaning that it continuously learns algorithms. For this reason, it is sometimes referred to as Machine Learning (ML). Newly designed medical devices that incorporate AI/ML by definition do not have a final “locked” design capable of a single FDA review. In April 2019, the FDA issued a white paper,